The global anticoagulants market was valued at USD 21.45 billion in 2018 and is anticipated to reach USD 80.29 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 9.9% over the forecast period. In 2018, North America emerged as the market leader, accounting for a significant share of 47.09%.
In recent years, the prevalence of critical and life-threatening diseases has been on the rise globally. Among these, cardiovascular diseases stand out as a major concern, driven by lifestyle changes associated with modern living. These conditions have underscored the growing importance of anticoagulant therapies in managing and mitigating associated health risks
Read More : https://www.fortunebusinessinsights.com/industry-reports/anticoagulants-market-101807
In February 2021, a groundbreaking study by Stony Brook University revealed that using anticoagulation therapy based on blood serum D-dimer levels significantly reduced mortality rates in critically ill COVID-19 patients. This development highlights the vital role of anticoagulants in managing severe conditions and underscores their growing importance in modern healthcare.
The anticoagulants market is witnessing robust growth, fueled by several key drivers: